Neue Alternativen zur Optimierung der Therapie von Krebs

Durch organspezifische Präparate ermöglichen wir Ihnen den Schritt in die Zukunft der patientenindividuellen Krebsdiagnose und optimierter Krebs Therapie. Die Formulierung der von uns angebotenen Kits machen die Synthese zum verwendungsfertigen Produkte einfach und schnell.

Lutetium 177 (Lu-177) chlorid

n.c.a (Trägerfrei) | Gefässform wählbar | wöchentliche Erhältlichkeit

Isotopia Molecular Imaging Ltd. (“Isotopia”) is a unique nuclear pharmacy established in Israel since 2006, and has become an essential supplier for the growing field of nuclear medicine in Israel.

Isotopia, founded by a highly trained group of senior professionals, experienced in all aspects of radiopharmacy operations, in collaboration with a group of Canadian investors.

Nowadays, Isotopia is taking steps for becoming a major worldwide supplier of Lu-177 to be used in the field of molecular radiotherapy.

Our aim is to supply Lu -177 according to costumers needs. By producing Lu-177 C.A and Lu-177 N.C.A, we can provide you both products according to your needs, tailor-made.

Die wichtigsten Vorteile:

  • Continuous supply of Lu-177 C.A guaranteed due to cooperation with
    various nuclear reactors.
  • Availability- on a weekly basis all year round
  • You choose your volume (fixed concentration)
  • V Shaped for minimum material loss .
  • Each lot is tested for labeling efficiency

Ordering Process

3 simple Steps: just define

Icon Step 1 calibration day

1. The calibration day

Step 2 The requested volume

2. The requested volume

Step 3 The requested activity

3. The requested activity at calibration day

Lu-177 Isotopia

Get Lu 177 according to your needs

Product Specifications

3 simple Steps: just define

Radionuclide177LU Lutetium Chloride Solution
Half -life6.65 days
Decay ModeBeta decay
Chemical formLuCl3 in 0.04 HCI

AppearanceClear, colorless solutionClear, colorless solution
pH1.0 — 2.01.0 — 2.0
IdentificationGamma photons with 208 KeV and 113 KeV presentGamma photons with 208 KeV and 113 KeV present
Specific Activity
(by ICP-OES at end
of production)
>740 GBq/mg
(>20 Ci/mg)
>3,000 GBq/mg
Chemical Purity
(by ICP-OES)
Cu ≤ 1.0 μg/GBq
Fe ≤ 0.5 μg/GBq
Pb ≤ 0.5 μg/GBq
Zn ≤ 1.0 μg/GBq
Cu ≤1.0 μg/GBq
Fe ≤0.5 μg/GBq
Pb ≤0.5 μg/GBq
Zn ≤1.0 μg/GBq
176Yb≤1.0 μg/GBq
(Gamma spectrometry)
177mLu <0.07%175Yb < 0.1%
The total radioactivity due to other
radionuclidic impurities < 0.01%
The total radioactivity due to other
radionuclidic impurities < 0.01%
(by iTLC)
[177Lu]lutetium(III) ion > 99%[177Lu]lutetium(III) ion > 99%
Bacterial Endotoxins35 < EU/ml35 < EU/ml
SterilityRetrospectively tested after decay